China Mobile, the world's biggest wireless carrier by users, is moving closer to a deal to take over Hong Kong broadband company HKBN after rival bidder I Squared Capital dropped out of the race, three sources said.

Qatar is Hong Kong's third-largest trading partner in the Middle East with bilateral trade in goods worth US$1.6 billion last year. Mr Lee said that there is plenty of room for further growth in trade and business between the two places.

Singapore biotech firm Mirxes began trading in Hong Kong on May 23 at a valuation exceeding US$1 billion. Read more at straitstimes.com. Read more at straitstimes.com.

By Scott Murdoch SYDNEY (Reuters) -Chinese drug developer Jiangsu Hengrui Pharmaceuticals has priced its stock offering on the Hong Kong Stock Exchange at HK$44.05 a share, the top of its price range,

Hong Kong-trade shares in CATL, the world’s largest maker of batteries for electric vehicles, have jumped after the company raised around $4.6 billion in the biggest initial public offering globally this year.

Chinese pharmaceutical stocks got a boost from a strong debut of Jiangsu Hengrui Pharmaceuticals, the nation’s biggest drug maker by market capitalisation, which surged 29 per cent on its debut in Hong Kong. CSPC Pharmaceutical Group rallied 4.3 per cent to HK$6.76 and Wuxi AppTec advanced 2.7 per cent to HK$68.90.

The developer wants to refinance $11 bln of loans but CEO Echo Huang has yet to reverse a 4-year revenue slump. Lenders including HSBC must weigh up the money-losing borrower's problems against the pain a default could inflict on the rest of their property exposure in the city.